Semax 10mg

Description

Semax Research Topics:

1. Protein Expression Studies:

   Semax is a research peptide examined for its effects on  (BDNF) and Nerve Growth Factor (NGF) expression in cellular research. (PMID: 16996037)

2. Neurochemical Activity:

   Research has examined Semax in preclinical models for its effects on neurotransmitters and related signaling processes. (PMID: 16996037)

3. Neurotransmitter Pathway Research:

   Semax is a research peptide examined for its effects on signaling pathways involving neurotransmitters such as serotonin and dopamine. (PMID: 28702721)

4. Cell Signaling Studies:

   Semax is a research peptide examined for its influence on cellular signaling processes associated with cytokine activity. (PMID: 31028579)

Peer-Reviewed Studies 

• The study of chronic partial denervation and quality of life in patients with motor neuron disease treated with semax. Serdiuk, A. V., Levitskiĭ, G. N., Miasoedov, N. F., & Skvortsova, V. I. (2007). S.S. Korsakova, 107(4), 29–39.

• Semax, a synthetic ACTH(4-10) analogue, attenuates behavioural and neurochemical alterations following early-life fluvoxamine exposure in white rats. Glazova, N. Y., Manchenko, D. M., Volodina, M. A., Merchieva, S. A., Andreeva, L. A., Kudrin, V. S., Myasoedov, N. F., & Levitskaya, N. G. (2021). Neuropeptides, 86, 102114. https://doi.org/10.1016/j.npep.2020.102114

Structure

Sequence: Ac-Met-Glu-His-Phe-Pro-Gly-Pro

Molecular Formula: C39Hs4N10010S

Molecular Weight 854.99 g/mol

PubChem CID: 122178

CAS Number: 80714-61-
Synonyms: Pro-Gly-Pro-ACTH